Camden National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.11M | Sell |
20,462
-204
| -1% | -$90.8K | 1.31% | 32 |
|
|
2025
Q1 | $10M | Sell |
20,666
-271
| -1% | -$131K | 1.49% | 28 |
|
|
2024
Q4 | $8.43M | Sell |
20,937
-187
| -0.9% | -$75.3K | 1.26% | 35 |
|
|
2024
Q3 | $9.82M | Sell |
21,124
-188
| -0.9% | -$87.4K | 1.41% | 33 |
|
|
2024
Q2 | $9.99M | Buy |
21,312
+2,742
| +15% | +$1.29M | 1.54% | 26 |
|
|
2024
Q1 | $7.76M | Sell |
18,570
-588
| -3% | -$246K | 1.37% | 38 |
|
|
2023
Q4 | $7.8M | Sell |
19,158
-500
| -3% | -$203K | 1.45% | 33 |
|
|
2023
Q3 | $6.84M | Buy |
19,658
+1,053
| +6% | +$366K | 1.4% | 34 |
|
|
2023
Q2 | $6.55M | Sell |
18,605
-272
| -1% | -$95.7K | 1.28% | 38 |
|
|
2023
Q1 | $5.95M | Sell |
18,877
-203
| -1% | -$64K | 1.21% | 40 |
|
|
2022
Q4 | $5.51M | Sell |
19,080
-348
| -2% | -$100K | 1.15% | 42 |
|
|
2022
Q3 | $5.63M | Sell |
19,428
-91
| -0.5% | -$26.3K | 1.26% | 41 |
|
|
2022
Q2 | $5.5M | Buy |
19,519
+204
| +1% | +$57.5K | 1.14% | 46 |
|
|
2022
Q1 | $5.04M | Sell |
19,315
-492
| -2% | -$128K | 0.91% | 51 |
|
|
2021
Q4 | $4.35M | Buy |
19,807
+281
| +1% | +$61.7K | 0.76% | 56 |
|
|
2021
Q3 | $3.54M | Sell |
19,526
-6,606
| -25% | -$1.2M | 0.68% | 60 |
|
|
2021
Q2 | $5.27M | Sell |
26,132
-1,232
| -5% | -$248K | 0.99% | 49 |
|
|
2021
Q1 | $5.88M | Sell |
27,364
-31
| -0.1% | -$6.66K | 1.17% | 41 |
|
|
2020
Q4 | $6.47M | Buy |
27,395
+11,561
| +73% | +$2.73M | 1.35% | 34 |
|
|
2020
Q3 | $4.31M | Buy |
15,834
+8,617
| +119% | +$2.34M | 0.95% | 47 |
|
|
2020
Q2 | $2.1M | Buy |
+7,217
| New | +$2.1M | 0.52% | 54 |
|